Skip to main content
Top
Published in: Journal of Cancer Education 3/2018

01-06-2018

Development of a Tool to Guide Parents Carrying a BRCA1/2 Mutation Share Genetic Results with Underage Children

Authors: Ariane Santerre-Theil, Karine Bouchard, Dominique St-Pierre, Anne-Marie Drolet, Jocelyne Chiquette, Michel Dorval, on behalf of Centre ROSE

Published in: Journal of Cancer Education | Issue 3/2018

Login to get access

Abstract

Although most parents carrying a BRCA1/2 genetic mutation share their test result with their underage children, they report needing support to decide if, when, and how to share risk information and what reactions to expect from their children. We developed a tool to guide parents carrying a BRCA1/2 mutation share their genetic result with underage children. Here, we report on the development of this tool using a qualitative methodology. A tool prototype was developed based on the International Patient Decision Aids Standards Collaboration framework. Content was assessed using feedback from focus groups, individual interviews, and a 12-item reading grid. Participants were nine BRCA1/2 mutation carriers with underage children and three cancer genetics health professionals. Thematic content analysis was conducted on interview transcripts. The tool was developed using an iterative process until saturation of data. An independent advisory committee was involved in all steps of tool development until reaching consensus. Rather than a decision aid per se (to communicate or not), the parents wanted a more comprehensive tool to help them communicate genetic test result to their children. To meet parents’ needs, a communication guidance booklet was developed, setting out the pros and cons of communication, steps to prepare sharing the test result, communication tips, and parents’ testimonies. This communication tool responds to a significant unmet need faced by parents carrying a genetic predisposition to cancer. Future studies are needed to assess how the information from the parent’s genetic test result impacts the child’s development, health behaviors, and relationship with the parent.
Appendix
Available only for authorised users
Literature
1.
go back to reference Botkin JR, Belmont JW, Berg JS, Berkman BE, Bombard Y, Holm IA, Levy HP, Ormond KE, Saal HM, Spinner NB (2015) Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 97(1):6–21CrossRefPubMedPubMedCentral Botkin JR, Belmont JW, Berg JS, Berkman BE, Bombard Y, Holm IA, Levy HP, Ormond KE, Saal HM, Spinner NB (2015) Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 97(1):6–21CrossRefPubMedPubMedCentral
2.
go back to reference Bradbury AR, Dignam JJ, Ibe CN, Auh SL, Hlubocky FJ, Cummings SA, White M, Olopade OI, Daugherty CK (2007) How often do BRCA mutation carriers tell their young children of the family’s risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol 25(24):3705–3711. doi:10.1200/JCO.2006.09.1900 CrossRefPubMed Bradbury AR, Dignam JJ, Ibe CN, Auh SL, Hlubocky FJ, Cummings SA, White M, Olopade OI, Daugherty CK (2007) How often do BRCA mutation carriers tell their young children of the family’s risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol 25(24):3705–3711. doi:10.​1200/​JCO.​2006.​09.​1900 CrossRefPubMed
3.
go back to reference Bradbury AR, Patrick-Miller L, Egleston BL, Schwartz LA, Sands CB, Shorter R, Moore CW, Tuchman L, Rauch P, Malhotra S (2012) Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls. Breast Cancer Res Treat 136(3):749–757CrossRefPubMedPubMedCentral Bradbury AR, Patrick-Miller L, Egleston BL, Schwartz LA, Sands CB, Shorter R, Moore CW, Tuchman L, Rauch P, Malhotra S (2012) Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls. Breast Cancer Res Treat 136(3):749–757CrossRefPubMedPubMedCentral
4.
go back to reference Bradbury AR, Patrick-Miller L, Pawlowski K, Ibe CN, Cummings SA, Hlubocky F, Olopade OI, Daugherty CK (2009) Learning of your parent’s BRCA mutation during adolescence or early adulthood: a study of offspring experiences. Psychooncology 18(2):200–208. doi:10.1002/pon.1384 CrossRefPubMedPubMedCentral Bradbury AR, Patrick-Miller L, Pawlowski K, Ibe CN, Cummings SA, Hlubocky F, Olopade OI, Daugherty CK (2009) Learning of your parent’s BRCA mutation during adolescence or early adulthood: a study of offspring experiences. Psychooncology 18(2):200–208. doi:10.​1002/​pon.​1384 CrossRefPubMedPubMedCentral
6.
go back to reference Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, Van der Weijden T (2013) A systematic development process for patient decision aids. BMC Med Inform Decis Mak 13(Suppl 2):S2CrossRefPubMedPubMedCentral Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, Van der Weijden T (2013) A systematic development process for patient decision aids. BMC Med Inform Decis Mak 13(Suppl 2):S2CrossRefPubMedPubMedCentral
7.
go back to reference Dibie-Krajcman D (2011) La loi no 2011-814 du 7 juillet 2011 relative à la bioéthique–Panorama. La Revue Sage-Femme 10(6):272–274CrossRef Dibie-Krajcman D (2011) La loi no 2011-814 du 7 juillet 2011 relative à la bioéthique–Panorama. La Revue Sage-Femme 10(6):272–274CrossRef
8.
go back to reference Dorval M, Bouchard K, Chiquette J (2014) Systematic review of educational tools used during the BRCA1/2 genetic testing process. Per Med 11(1):113–124CrossRef Dorval M, Bouchard K, Chiquette J (2014) Systematic review of educational tools used during the BRCA1/2 genetic testing process. Per Med 11(1):113–124CrossRef
9.
go back to reference Finkler L, Mykitiuk R, Nisker J, Pioro M (2014) Understanding the use of’Genetic Predisposition’in Canadian Legal Decisions. Revue de droit et santé de McGill 7(1):1–65 Finkler L, Mykitiuk R, Nisker J, Pioro M (2014) Understanding the use of’Genetic Predisposition’in Canadian Legal Decisions. Revue de droit et santé de McGill 7(1):1–65
10.
go back to reference Forrest K, Simpson SA, Wilson BJ, Van Teijlingen E, McKee L, Haites N, Matthews E (2003) To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 64(4):317–326CrossRefPubMed Forrest K, Simpson SA, Wilson BJ, Van Teijlingen E, McKee L, Haites N, Matthews E (2003) To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 64(4):317–326CrossRefPubMed
11.
go back to reference Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani AR (2010) Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy. Gynecol Endocrinol 26(8):568–577CrossRefPubMed Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani AR (2010) Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy. Gynecol Endocrinol 26(8):568–577CrossRefPubMed
12.
go back to reference Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C (2002) All in the family: evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet A 107(2):143–150CrossRef Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C (2002) All in the family: evaluation of the process and content of sisters’ communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet A 107(2):143–150CrossRef
13.
go back to reference Joly Y, Ngueng FI, Simard J (2013) Genetic discrimination and life insurance: a systematic review of the evidence. BMC Med 11(1):1CrossRef Joly Y, Ngueng FI, Simard J (2013) Genetic discrimination and life insurance: a systematic review of the evidence. BMC Med 11(1):1CrossRef
15.
go back to reference Moorman PG, Havrilesky LJ, Gierisch JM, Coeytaux RR, Lowery WJ, Urrutia RP, Dinan M, McBroom AJ, Hasselblad V, Sanders GD (2013) Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol 31(33):4188–4198CrossRefPubMed Moorman PG, Havrilesky LJ, Gierisch JM, Coeytaux RR, Lowery WJ, Urrutia RP, Dinan M, McBroom AJ, Hasselblad V, Sanders GD (2013) Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol 31(33):4188–4198CrossRefPubMed
16.
go back to reference O’Connor AM, Stacey D, Barry MJ, Col NF, Eden KB, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H (2007) Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Mak 27(5):554–574CrossRef O’Connor AM, Stacey D, Barry MJ, Col NF, Eden KB, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H (2007) Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Mak 27(5):554–574CrossRef
17.
go back to reference Patenaude, A F., T A. DeMarco, B N. Peshkin, H Valdimarsdottir, J E. Garber, K A. Schneider, L Hewitt, J Hamilton, and K P. Tercyak. 2012. Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Couns: 1–12 Patenaude, A F., T A. DeMarco, B N. Peshkin, H Valdimarsdottir, J E. Garber, K A. Schneider, L Hewitt, J Hamilton, and K P. Tercyak. 2012. Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice. J Genet Couns: 1–12
19.
go back to reference Peshkin BN, Demarco TA, Tercyak KP (2010) On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children. Familial Cancer 9(1):89–97. doi:10.1007/s10689-009-9267-3 CrossRefPubMed Peshkin BN, Demarco TA, Tercyak KP (2010) On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children. Familial Cancer 9(1):89–97. doi:10.​1007/​s10689-009-9267-3 CrossRefPubMed
20.
go back to reference Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD (2002) Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiol Biomark Prev 11(1):79–87 Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD (2002) Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population. Cancer Epidemiol Biomark Prev 11(1):79–87
21.
go back to reference Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D (2012) Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat 33(4):690–702CrossRefPubMedPubMedCentral Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D (2012) Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Hum Mutat 33(4):690–702CrossRefPubMedPubMedCentral
22.
go back to reference Sharff ME, DeMarco TA, Mays D, Peshkin BN, Valdimarsdottir HB, Garber JE, Schneider KA, Patenaude AF, Tercyak KP (2012) Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children. Genet Test Mol Biomarkers 16(5):376–382. doi:10.1089/gtmb.2011.0154 CrossRefPubMedPubMedCentral Sharff ME, DeMarco TA, Mays D, Peshkin BN, Valdimarsdottir HB, Garber JE, Schneider KA, Patenaude AF, Tercyak KP (2012) Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children. Genet Test Mol Biomarkers 16(5):376–382. doi:10.​1089/​gtmb.​2011.​0154 CrossRefPubMedPubMedCentral
23.
go back to reference Tercyak KP, Mays D, DeMarco TA, Peshkin BN, Valdimarsdottir HB, Schneider KA, Garber JE, Patenaude AF (2013) Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children. Cancer Epidemiol Biomark Prev 22(7):1260–1266. doi:10.1158/1055-9965.EPI-13-0198 CrossRef Tercyak KP, Mays D, DeMarco TA, Peshkin BN, Valdimarsdottir HB, Schneider KA, Garber JE, Patenaude AF (2013) Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children. Cancer Epidemiol Biomark Prev 22(7):1260–1266. doi:10.​1158/​1055-9965.​EPI-13-0198 CrossRef
24.
go back to reference Tercyak KP, Peshkin BN, DeMarco TA, Brogan BM, Lerman C (2002) Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Educ Couns 47(2):145–153CrossRefPubMed Tercyak KP, Peshkin BN, DeMarco TA, Brogan BM, Lerman C (2002) Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Educ Couns 47(2):145–153CrossRefPubMed
25.
Metadata
Title
Development of a Tool to Guide Parents Carrying a BRCA1/2 Mutation Share Genetic Results with Underage Children
Authors
Ariane Santerre-Theil
Karine Bouchard
Dominique St-Pierre
Anne-Marie Drolet
Jocelyne Chiquette
Michel Dorval
on behalf of Centre ROSE
Publication date
01-06-2018
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 3/2018
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-016-1127-x

Other articles of this Issue 3/2018

Journal of Cancer Education 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine